Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GMED Globus Medical	$53.26 -1.4%	$58.33	$51.87 ▼ $94.93	$7.32B	1.19	1.65 million shs	1.09 million shs
HOLX Hologic	$66.10 +0.2%	$63.14	$51.90 ▼ $84.67	$14.70B	0.55	1.84 million shs	1.54 million shs
PODD Insulet	$286.58 0.0%	$306.37	$173.00 ▼ $329.33	$20.17B	1.35	576,712 shs	672,078 shs
STE STERIS	$227.28 +0.8%	$237.95	$200.98 ▼ $252.79	$22.18B	0.92	654,806 shs	376,548 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GMED Globus Medical	+1.90%	-4.41%	-6.47%	-26.03%	-26.30%
HOLX Hologic	+0.89%	+3.27%	+2.36%	+13.14%	-15.56%
PODD Insulet	+0.39%	-0.56%	-6.83%	+10.52%	+45.70%
STE STERIS	+0.81%	-0.78%	-4.74%	-0.34%	-2.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GMED Globus Medical	4.9496 of 5 stars	4.3	5.0	0.0	4.1	3.1	2.5	1.9
HOLX Hologic	4.8104 of 5 stars	3.2	3.0	0.0	4.3	2.9	3.3	2.5
PODD Insulet	4.6057 of 5 stars	3.4	3.0	0.0	4.9	3.2	0.8	1.9
STE STERIS	4.8429 of 5 stars	3.4	3.0	4.2	3.8	2.6	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GMED Globus Medical	2.62	Moderate Buy	$90.09	69.15% Upside
HOLX Hologic	2.47	Hold	$77.33	16.99% Upside
PODD Insulet	2.83	Moderate Buy	$321.00	12.01% Upside
STE STERIS	2.75	Moderate Buy	$270.33	18.94% Upside

Current Analyst Ratings Breakdown

Latest GMED, STE, PODD, and HOLX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/22/2025	GMED Globus Medical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$97.00 ➝ $90.00
7/22/2025	STE STERIS	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$277.00 ➝ $288.00
7/21/2025	GMED Globus Medical	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/16/2025	HOLX Hologic	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$65.00 ➝ $70.00
7/15/2025	GMED Globus Medical	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $68.00
7/15/2025	STE STERIS	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$260.00 ➝ $276.00
7/9/2025	HOLX Hologic	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$60.00 ➝ $80.00
7/8/2025	PODD Insulet	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/8/2025	HOLX Hologic	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$62.00 ➝ $68.00
6/16/2025	PODD Insulet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$365.00
6/10/2025	GMED Globus Medical	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight

(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GMED Globus Medical	$2.52B	2.86	$6.56 per share	8.12	$30.40 per share	1.75
HOLX Hologic	$4.03B	3.66	$5.51 per share	11.99	$22.09 per share	2.99
PODD Insulet	$2.07B	9.74	$4.43 per share	64.62	$17.27 per share	16.59
STE STERIS	$5.46B	4.10	$14.37 per share	15.82	$67.33 per share	3.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GMED Globus Medical	$102.98M	$1.34	39.75	13.22	1.58	7.39%	10.52%	8.56%	8/7/2025 (Estimated)
HOLX Hologic	$789.50M	$2.37	27.89	14.31	2.42	13.83%	19.71%	10.87%	7/30/2025 (Estimated)
PODD Insulet	$418.30M	$5.56	51.54	57.66	2.56	18.29%	22.25%	8.29%	8/7/2025 (Confirmed)
STE STERIS	$614.64M	$6.20	36.66	22.89	N/A	11.26%	14.21%	9.13%	8/6/2025 (Estimated)

Latest GMED, STE, PODD, and HOLX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	GMED Globus Medical	$0.79	N/A	N/A	N/A	$738.91 million	N/A
8/7/2025	Q2 2025	PODD Insulet	$0.9290	N/A	N/A	N/A	$612.31 million	N/A
8/6/2025	Q1 2026	STE STERIS	$2.32	N/A	N/A	N/A	$1.36 billion	N/A
7/30/2025	Q3 2025	HOLX Hologic	$1.05	N/A	N/A	N/A	$1.01 billion	N/A
5/14/2025	Q4 2025	STE STERIS	$2.59	$2.74	+$0.15	$1.47	$1.47 billion	$1.48 billion
5/8/2025	Q1 2025	GMED Globus Medical	$0.74	$0.68	-$0.06	$0.54	$629.74 million	$598.12 million
5/8/2025	Q1 2025	PODD Insulet	$0.81	$1.02	+$0.21	$0.50	$543.20 million	$569.00 million
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.28	1.00%	N/A	36.77%	20 Years

Latest GMED, STE, PODD, and HOLX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/7/2025	STE STERIS	quarterly	$0.57	1.01%	6/10/2025	6/10/2025	6/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GMED Globus Medical	N/A	4.45	2.72
HOLX Hologic	0.54	3.24	2.52
PODD Insulet	1.21	4.47	3.63
STE STERIS	0.29	1.96	1.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GMED Globus Medical	95.16%
HOLX Hologic	94.73%
PODD Insulet	N/A
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
GMED Globus Medical	18.51%
HOLX Hologic	1.88%
PODD Insulet	0.39%
STE STERIS	1.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GMED Globus Medical	5,300	135.38 million	110.32 million	Optionable
HOLX Hologic	7,063	222.85 million	218.66 million	Optionable
PODD Insulet	3,900	70.38 million	70.10 million	Optionable
STE STERIS	17,787	98.37 million	97.32 million	Optionable

GMED, STE, PODD, and HOLX Headlines

Recent News About These Companies

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results ...

July 24 at 4:48 PM | seekingalpha.com

Crestwood Advisors Group LLC Invests $1.40 Million in STERIS plc (NYSE:STE)

July 23 at 5:06 AM | marketbeat.com

Victory Capital Management Inc. Raises Stock Position in STERIS plc (NYSE:STE)

July 23 at 4:12 AM | marketbeat.com

STERIS PLC (STE) Announces Upcoming Conference Call for Fiscal 2026 Q1 Results | STE stock news

July 22 at 5:25 PM | gurufocus.com

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

July 22 at 4:30 PM | globenewswire.com

KeyCorp Boosts STERIS (NYSE:STE) Price Target to $288.00

July 22 at 1:18 PM | marketbeat.com

Sustainable Growth Advisers LP Sells 67,156 Shares of STERIS plc (NYSE:STE)

July 22 at 12:46 PM | marketbeat.com

Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

July 22 at 10:35 AM | zacks.com

OneAscent Family Office LLC Invests $405,000 in STERIS plc (NYSE:STE)

July 20, 2025 | marketbeat.com

STERIS (NYSE:STE) Cut to "Buy" at Wall Street Zen

July 19, 2025 | marketbeat.com

STERIS plc (NYSE:STE) Stock Holdings Lessened by New York State Common Retirement Fund

July 19, 2025 | marketbeat.com

Rep. April McClain Delaney Sells STERIS plc (NYSE:STE) Shares

July 18, 2025 | marketbeat.com

STERIS plc (NYSE:STE) Shares Sold by Segall Bryant & Hamill LLC

July 18, 2025 | marketbeat.com

Equities Analysts Offer Predictions for STERIS Q2 Earnings

July 18, 2025 | americanbankingnews.com

Zacks Research Weighs in on STERIS's Q3 Earnings (NYSE:STE)

July 17, 2025 | marketbeat.com

Edgestream Partners L.P. Raises Holdings in STERIS plc (NYSE:STE)

July 17, 2025 | marketbeat.com

1,180 Shares in STERIS plc (NYSE:STE) Purchased by Ballentine Partners LLC

July 17, 2025 | marketbeat.com

STERIS (NYSE:STE) Raised to Overweight at Morgan Stanley

July 17, 2025 | americanbankingnews.com

Zacks Research Weighs in on STERIS's Q2 Earnings (NYSE:STE)

July 16, 2025 | marketbeat.com

Morgan Stanley Upgrades STERIS (STE)

July 16, 2025 | msn.com

Brown Advisory Inc. Sells 27,667 Shares of STERIS plc (NYSE:STE)

July 16, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
By Chris Markoch | June 25, 2025
View Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
Top Steel Picks for the Coming Infrastructure Boom
By Chris Markoch | June 25, 2025
View Top Steel Picks for the Coming Infrastructure Boom
3 Notable Stocks Just Split: Which One Could Be the Big Winner?
By Leo Miller | June 26, 2025
View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?
Rocket Lab: Latest Catalysts Bolster the Bull Case
By Ryan Hasson | July 3, 2025
View Rocket Lab: Latest Catalysts Bolster the Bull Case
3 Overbought Stocks Ripe for a Pullback
By Ryan Hasson | July 7, 2025
View 3 Overbought Stocks Ripe for a Pullback

GMED, STE, PODD, and HOLX Company Descriptions

Globus Medical NYSE:GMED

$53.26 -0.78 (-1.44%)

Closing price 03:59 PM Eastern

Extended Trading

$53.26 +0.00 (+0.01%)

As of 07:56 PM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Hologic NASDAQ:HOLX

$66.10 +0.15 (+0.23%)

Closing price 04:00 PM Eastern

Extended Trading

$64.50 -1.60 (-2.43%)

As of 05:00 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Insulet NASDAQ:PODD

$286.58 -0.09 (-0.03%)

Closing price 04:00 PM Eastern

Extended Trading

$294.42 +7.85 (+2.74%)

As of 06:55 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS NYSE:STE

$227.28 +1.81 (+0.80%)

Closing price 03:59 PM Eastern

Extended Trading

$227.26 -0.02 (-0.01%)

As of 04:29 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time